Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue SUPPL. 2, 2006, Pages

  Welsh, James S ^a   Kennedy, Andrew S ^b   Thomadsen, Bruce ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Wake Radiology Oncology   (United States)

Author keywords

Colorectal adenocarcinoma; Liver metastases; Selective internal radiation therapy

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; ONCOLOGY; PATIENT TREATMENT; RADIOLOGY; SURGERY;

COLORECTAL ADENOCARCINOMA; LIVER METASTASES; SELECTIVE INTERNAL RADIATION THERAPY;

RADIOTHERAPY;

ANALGESIC AGENT; ANTIEMETIC AGENT; BEVACIZUMAB; CETUXIMAB; CHROMIUM 51; COBALT 57; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; GOLD 198; HISTAMINE H2 RECEPTOR ANTAGONIST; IODINE 125; IRINOTECAN; MICROSPHERE; OXALIPLATIN; PHOSPHORUS 32; PROTON PUMP INHIBITOR; SAMARIUM 153; SCANDIUM 46; TECHNETIUM 99M; YTTRIUM 90;

ABDOMINAL DISCOMFORT; ADENOCARCINOMA; ANOREXIA; ARTICLE; BETA RADIATION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CARCINOMA; DOSIMETRY; EX VIVO STUDY; FATIGUE; FEVER; HUMAN; INTERVENTIONAL RADIOLOGY; LIVER FUNCTION TEST; LIVER METASTASIS; LIVER TUMOR; MULTIMODALITY CANCER THERAPY; NAUSEA; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION SAFETY; SELECTIVE INTERNAL RADIATION THERAPY; SURVIVAL RATE; TUMOR; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ALGORITHMS; BRACHYTHERAPY; CELL HYPOXIA; COLORECTAL NEOPLASMS; HUMANS; LIVER; LIVER NEOPLASMS; MICROSPHERES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; TECHNETIUM TC 99M AGGREGATED ALBUMIN; YTTRIUM RADIOISOTOPES;

EID: 33748463544     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.09.011     Document Type: Article

References (70)

1. Dienstag J.L., and Isselbacher K.J. Tumors of the liver and biliary tract. In: Kasper D.L., Braunwald E., Fauci A.S., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrison's principles of internal medicine. 16th edition (2005)
2. Rabeneck L., El-Serag H.B., Davila J.A., et al. Outcomes of colorectal cancer in the United States: No change in survival (1986-1997). Am J Gastroenterol 98 (2003) 471-477
3. Lawrence T.S., Tesser R.J., and ten Haken R.K. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 19 (1990) 1041-1047
4. Lawrence T.S., ten Haken R.K., Tesser R.J., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
5. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
6. Herfarth K.K., Debus J., Lohr F., et al. Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial. J Clin Oncol 19 (2001) 164-170
7. Mirza A.N., Fornage B.D., Sneige N., et al. Radiofrequency ablation of solid tumors. Cancer J 7 (2001) 95-102
8. Nijsen J.F.W., Zonnenberg B.A., Woittiez J.R.W., et al. Holmium-166 polylactic acid microspheres applicable for intra-arterial radionuclide therapy of hepatic malignancies: Effects of preparation and neutron activation techniques. Euro J Nucl Med 26 (1999) 699-704
9. Seppenwoolde J.H., Nijsen J.F., Bartels L.W., et al. Internal radiation therapy of liver tumors: Qualitative and quantitative magnetic resonance imaging of the biodistribution of holmium-loaded microspheres in animal models. Magn Reson Med 53 (2005) 76-84
10. Nijsen J.F., Seppenwoolde J.H., Havenith T., et al. Liver tumors: MR imaging of radioactive holmium microspheres-phantom and rabbit study. Radiology 231 (2004) 491-499
11. Adnani N. Dosimetry of in situ activated dysprosium microspheres. Phys Med Biol 49 (2004) 733-746
12. Kennedy A.S., Nutting C., Coldwell D., et al. Pathologic response and microdosimetry of (90)Y microspheres in man: Review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60 (2004) 1552-1563
13. Kennedy A.S., and Salem R. Comparison of two 90Yttrium microsphere agents for hepatic artery brachytherapy (2003) 156 Proceedings of the 14th International Congress on Anti-Cancer Treatment
14. Breedis C., and Young G. The blood supply of neoplasms in the liver. Am J Pathol 30 (1954) 969-984
15. Ackerman N.B., Lien W.M., Kondi E.S., et al. The blood supply of experimental liver metastases. I: The distribution of hepatic artery and portal vein blood to "small" and "large" tumors. Surgery 66 (1970) 1067-1072
16. Lien W.M., and Ackerman N.B. The blood supply of experimental liver metastases. II: A microcirculatory study of the normal and tumor vessels of the liver with the use of perfused silicone rubber. Surgery 68 (1970) 334-340
17. Meade V.M., Burton M.A., Gray B.N., et al. Distribution of different sized microspheres in experimental hepatic tumours. Eur J Cancer Clin Oncol 23 (1987) 37-41
18. Hirst D.G. Blood flow and its modulation in malignant tumors. In: Willmott N., and Daly J.M. (Eds). Microspheres and regional cancer therapy (1994), CRC Press, Boca Raton, FL 31-56
19. Willmott N., Goldberg J., Anderson J., et al. Abnormal vasculature of solid tumours: Significance for microsphere-based targeting strategies. Int J Radiat Biol 60 (1991) 195-199
20. Burton M.A., Gray B.N., and Coletti A. Effect of angiotensin II on blood flow in the transplanted sheep squamous cell carcinoma. Eur J Cancer Clin Oncol 24 (1988) 1373-1376
21. Jirtle R.L., Klifton K.H., and Rankin J.H.G. Measurement of mammary tumor blood flow in unanesthetized rats. J Natl Cancer Inst 60 (1978) 811
22. Sarfaraz M., Kennedy A.S., Cao Z.J., et al. Radiation dose distribution in patients treated with Y-90 microspheres for non-resectable hepatic tumors. Int J Radiat Oncol Biol Phys 51 (2001) 32-33
23. Sarfaraz M., Kennedy A.S., Cao Z.J., et al. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30 (2003) 199-203
24. Ya P.M., Guzman T., Loken M.K., et al. Isotope localization with tagged microspheres. Surgery 49 (1961) 644-650
25. Kim Y.S., LaFave J.W., and MacLean L.D. The use of radiating microspheres in the treatment of experimental and human malignancy. Surgery 52 (1962) 220-231
26. Grady E.D., Sale W.T., and Rollins L.C. Localization of radioactivity by intravascular injection of large radioactive particles. Ann Surg 157 (1963) 97-114
27. Burton M.A., Gray B.N., Klemp P.F., et al. Selective internal radiation therapy: Distribution of radiation in the liver. Eur J Cancer Clin Oncol 25 (1989) 1487-1491
28. Fox R.A., Klemp P.F., Egan G., et al. Dose distribution following selective internal radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 463-467
29. Campbell A.M., Bailey I.H., and Burton M.A. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 45 (2000) 1023-1033
30. Campbell A.M., Bailey I.H., and Burton M.A. Tumor dosimetry in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 46 (2001) 487-498
31. Austin-Seymour M.M., Chen G.T.Y., Castro J.R., et al. Dose-volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 12 (1986) 31-35
32. Ingold J.A., Reed G.B., Kaplan H.S., and Bagshaw M.A. Radiation hepatitis. Am J Roentgenol 93 (1965) 200-208
33. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
34. Poussin-Rosllo H., Nisce L.Z., and D'Angelo G.J. Hepatic radiation tolerance in Hodgkin's disease patients. Radiology 121 (1976) 461-464
35. Andrews J.C., Ackerman R.J., Cotton L.A., et al. Hepatic radioembolization with yttrium-90 containing glass microspheres. Preliminary results and clinical follow-up. J Nucl Med 35 (1994) 1637-1644
36. Lau W.Y., Ho S., Leung T.W., et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40 (1998) 583-592
37. Burton M.A., Gray B.N., Kelleher D.K., et al. Selective internal radiation therapy: Validation of intraoperative dosimetry. Radiology 175 (1990) 253-255
38. Burton M.A., Gray B.N., Jones C., et al. Intraoperative dosimetry of 90Y in liver tissue. Int J Rad Appl Instrum B 16 (1989) 495-498
39. Gray B.N., Burton M.A., Kelleher D., et al. Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys 18 (1990) 619-623
40. Yorke E.D., Jackson A., Fox R.A., et al. Can current models explain the lack of liver complications in Y-90 microsphere therapy. Clin Cancer Res 5 (1999) 3024S-3030S
41. Moroz P., Anderson J.E., Van Hazel G., and Gray B.N. Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume. J Surg Oncol 78 (2001) 248-252
42. Wickremesekera J.K., Chen W., Cannan R.J., et al. Serum proinflammatory cytokine response in patients with advanced liver tumors following selective internal radiation therapy (SIRT) with 90Yttrium microspheres. Int J Radiat Oncol Biol Phys 49 (2001) 1015-1021
43. Thamboo T.P., Tan K.-B., Wang S.-C., and Manuel S.-T. Extrahepatic embolisation of Y-90 microspheres from selective internal radiation therapy (SIRT) of the liver. Pathology 34 (2003) 351-353
44. Leung T.W.T., Lau W.Y., Ho S.K.W., et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90-Yttrium microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys 33 (1995) 919-924
45. Muller J.H., and Rossier P.H. Treatment of cancer of the lungs by artificial radioactivity. Experientia 3 (1947) 75
46. 198). Acta Radiol 35 (1951) 449-468
47. Ariel I.M. Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration radioactive isotopes (Y90 radiating microspheres). Ann Surg 162 (1965) 267-278
48. Ariel I.M., and Pack G.T. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer 20 (1967) 793-804
49. Nolan T., Grady E.D., and Crumbley A.J. Regional internal radiation for hepatic cancer. Minerva Oncol 1 (1973) 104-106
50. Grady E.D., Nolan T., Larose J.H., et al. Internal hepatic radiotherapy. II: Intra-arterial radiocolloid therapy for hepatic tumors. Am J Roentgenol Ther Nucl Med 124 (1975) 596-599
51. Blanchard R.J., Grotenhuis I., and LaFave J.W. Treatment of experimental tumors: Utilization of radioactive microspheres. Arch Surg 89 (1964) 406.
52. Blanchard R.J., LaFave J.W., and Kim T.S. Treatment of patients with advanced cancer using Y-90 microspheres. Cancer 18 (1965) 375-380
53. Dogliotti A.M., Caldarola L., and Badellino F. Endoarterial regional injection of radioisotopes in the treatment of malignant tumours. IJARI 17 (1966) 51-59
54. Caldarola L., Rosa U., and Badellino F. Preparation of 32P labelled resin microspheres for radiation treatment of tumors by intraarterial injection. Panminerva Med 7 (1965) 102
55. Grady E.D. Internal radiation therapy of hepatic cancer. Dis Colon Rectum 22 (1979) 371-375
56. Grady E.D. Intrahepatic arterial 90-yttrium resin spheres to treat liver cancer. Int J Nucl Med Biol 5 (1978) 253-254
57. Burton M.A., Gray B.N., Klemp P.F., Kelleher D.K., and Hardy N. Selective internal radiation therapy: Distribution of radiation in the liver. Eur J Cancer Clin Oncol 25 (1989) 1487-1491
58. Burton M.A., Gray B.N., Self G.W., Heggie J.C., and Townsend P.S. Manipulation of experimental rat and rabbit liver tumor blood flow with angiotensin II. Cancer Res 45 (1985) 5390-5393
59. Gray B.N., Burton M.A., Kelleher D.K., et al. Selective internal radiation (SIR) therapy for treatment of liver metastases: Measurement of response rate. J Surg Oncol 42 (1989) 192-196
60. Gray B.N., Anderson J.E., Burton M.A., et al. Regression of liver metastases following treatment with yttrium-90 microspheres. Aust N Z J Surg 62 (1992) 105-110
61. Stubbs R.S., Cannan R.J., and Mitchell A.W. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48 (2001) 333-337
62. Stubbs R.S., Cannan R.J., and Mitchell A.W. Selective internal radiation therapy with 90yttrium microspheres for extensive colorectal liver metastases. J Gastrointest Surg 5 (2001) 294-302
63. Van Hazel G., Blackwell A., Anderson J., et al. Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88 (2004) 78-85
64. Gray B.N., Van Hazel G., Hope M., et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (2001) 1711-1720
65. Kennedy A.S., Coldwell D., Nutting C., et al. Liver brachytherapy for unresectable colorectal metastases: US results 2000-2004 (2005) 155 [Abstract] Proceedings of the 2005 ASCO Gastrointestinal Cancers Symposium.
66. Huie M., Greiner L., Thomas J., et al. Institutional series of selective internal radiation therapy (SIRT) for liver predominant metastatic colorectal cancer (MCRC). J Clin Oncol 22 (2004) 3665
67. Kennedy A.S., Coldwell D., Nutting C., et al. 90Y-microspheres in the treatment of colorectal metastases: USA experience. In: Khayat D., and Hortobagyi G.N. (Eds). Fifteenth International Congress on Anti-Cancer Treatment (2004), T. C. O, Paris, France 285
68. Welsh JS, Huie M, Greiner L, et al. Selective internal radiation therapy (SIRT) for hepatic metastases from colorectal adenocarcinoma: Initial experience at the University of Wisconsin. Cancer J (Proc Am Radium Soc 2005). In press.
69. Van Hazel G., Price D., Bower G., et al. Selective internal radiation therapy (SIRT) plus chemotherapy with FOLFOX 4. A phase I dose escalation study (2005) 216 Proceedings of the 2005 Gastrointestinal Cancers Symposium
70. Van Hazel G., Price D., Cardaci J., et al. Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study (2005) 137 Proceedings of the 2005 Gastrointestinal Cancers Symposium